Wells Fargo’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-152
| Closed | -$404 | – | 6769 |
|
|
2024
Q1 | $404 | Buy |
152
+3
| +2% | +$8 | ﹤0.01% | 5934 |
|
|
2023
Q4 | $618 | Buy |
149
+16
| +12% | +$66 | ﹤0.01% | 5890 |
|
|
2023
Q3 | $184 | Buy |
133
+66
| +99% | +$91 | ﹤0.01% | 6234 |
|
|
2023
Q2 | $210 | Buy |
67
+3
| +5% | +$9 | ﹤0.01% | 6380 |
|
|
2023
Q1 | $218 | Buy |
64
+11
| +21% | +$37 | ﹤0.01% | 6431 |
|
|
2022
Q4 | $237 | Buy |
53
+2
| +4% | +$9 | ﹤0.01% | 6244 |
|
|
2022
Q3 | $0 | Buy |
51
+9
| +21% | – | ﹤0.01% | 6734 |
|
|
2022
Q2 | $0 | Buy |
+42
| New | – | ﹤0.01% | 6889 |
|
|
2021
Q4 | – | Sell |
-521
| Closed | -$21K | – | 6987 |
|
|
2021
Q3 | $21K | Sell |
521
-57
| -10% | -$2.3K | ﹤0.01% | 5642 |
|
|
2021
Q2 | $9K | Sell |
578
-1
| -0.2% | -$16 | ﹤0.01% | 5844 |
|
|
2021
Q1 | $12K | Sell |
579
-4,111
| -88% | -$85.2K | ﹤0.01% | 5918 |
|
|
2020
Q4 | $106K | Buy |
4,690
+4,363
| +1,334% | +$98.6K | ﹤0.01% | 5175 |
|
|
2020
Q3 | $7K | Buy |
327
+318
| +3,533% | +$6.81K | ﹤0.01% | 5637 |
|
|
2020
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 6173 |
|
|
2020
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 6137 |
|
|
2019
Q1 | – | Sell |
-30
| Closed | -$1K | – | 5979 |
|
|
2018
Q4 | $1K | Sell |
30
-125
| -81% | -$4.17K | ﹤0.01% | 5795 |
|
|
2018
Q3 | $12K | Buy |
155
+65
| +72% | +$5.03K | ﹤0.01% | 5572 |
|
|
2018
Q2 | $8K | Buy |
+90
| New | +$8K | ﹤0.01% | 5643 |
|